Tata 1mg, a digital healthcare platform, on Friday announced that one-third of the people who tested for HbA1c at Tata 1mg Labs, were found to have diabetes, with the highest incidence reported among the 40-60 years age group.
source https://www.pharmatutor.org/pharma-news/2022/one-in-three-of-people-tested-diabetes-in-india
No comments:
Post a Comment